Korean J Gastroenterol.  2020 Jun;75(6):322-332. 10.4166/kjg.2020.75.6.322.

Guidelines for Non-variceal Upper Gastrointestinal Bleeding

• Kim JS
• Kim BW
• Kim DH
• Park CH
• Lee H
• Joo MK
• Jung DH
• Chung JW
• Choi HS
• Baik GH
• Lee JH
• Song KY
• Hur S
• The Korean Society of Gastroenterology
• Korean College of Helicobacter and Upper Gastrointestinal Research
• Korean Society of Gastrointestinal Endoscopy
• The Korean Gastric Cancer Association and Korean Society of Interventional Radiology

• KMID: 2504374
• DOI: http://doi.org/10.4166/kjg.2020.75.6.322

Abstract

Non-variceal upper gastrointestinal bleeding (NVUGIB) refers to bleeding that develops in the gastrointestinal tract proximal to the ligament of Treitz. NVUGIB is an important cause for visiting the hospital and is associated with significant morbidity and mortality. Although European and Asian-Pacific guidelines have been published, there has been no previous guidelines regarding management of NVUGIB in Korea. Korea is a country with a high prevalence of Helicobacter pylori infection and patients have easy accessibility to receive endoscopy. Therefore, we believe that guidelines regarding management of NVUGIB are mandatory. The Korean Society of Gastroenterology reviewed recent evidence and recommends practical management guidelines on NVUGIB in Korea.

Keyword

Non-variceal upper gastrointestinal bleeding; Non-steroidal anti-inflammatory drug; Anti-thrombotics; Guideline

Reference

1. Laine L. 2016; Clinical practice. Upper gastrointestinal bleeding due to a peptic ulcer. N Engl J Med. 374:2367–2376. DOI: 10.1056/NEJMcp1514257. PMID: 27305194.

2. Laine L, Yang H, Chang SC, Datto C. 2012; Trends for incidence of hospitalization and death due to GI complications in the United States from 2001 to 2009. Am J Gastroenterol. 107:1190–1195. quiz 1196. DOI: 10.1038/ajg.2012.168. PMID: 22688850.

3. Quan S, Frolkis A, Milne K, et al. 2014; Upper-gastrointestinal bleeding secondary to peptic ulcer disease: incidence and outcomes. World J Gastroenterol. 20:17568–17577. DOI: 10.3748/wjg.v20.i46.17568. PMID: 25516672. PMCID: PMC4265619.

4. Tielleman T, Bujanda D, Cryer B. 2015; Epidemiology and risk factors for upper gastrointestinal bleeding. Gastrointest Endosc Clin N Am. 25:415–428. DOI: 10.1016/j.giec.2015.02.010. PMID: 26142028.

5. Gralnek IM, Dumonceau JM, Kuipers EJ, et al. 2015; Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 47:a1–a46. DOI: 10.1055/s-0034-1393172. PMID: 26417980.

6. Sung JJ, Chiu PW, Chan FKL, et al. 2018; Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018. Gut. 67:1757–1768. DOI: 10.1136/gutjnl-2018-316276. PMID: 29691276. PMCID: PMC6145289.

7. Lee JH, Choi KD, Jung HY, et al. 2018; Seroprevalence of Helicobacter pylori in Korea: a multicenter, nationwide study conducted in 2015 and 2016. Helicobacter. 23:e12463. DOI: 10.1111/hel.12463. PMID: 29345022. PMCID: PMC5900911.

8. Chung IK, Lee DH, Kim HU, et al. 2009; Guidelines of treatment for bleeding peptic ulcer disease. Korean J Gastroenterol. 54:298–308. DOI: 10.4166/kjg.2009.54.5.298. PMID: 19934611.

9. Rockall TA, Logan RF, Devlin HB, Northfield TC. 1996; Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 38:316–321. DOI: 10.1136/gut.38.3.316. PMID: 8675081. PMCID: PMC1383057.

10. Wang CY, Qin J, Wang J, Sun CY, Cao T, Zhu DD. 2013; Rockall score in predicting outcomes of elderly patients with acute upper gastrointestinal bleeding. World J Gastroenterol. 19:3466–3472. DOI: 10.3748/wjg.v19.i22.3466. PMID: 23801840. PMCID: PMC3683686.

11. Cieniawski D, Kuźniar E, Winiarski M, Matłok M, Kostarczyk W, Pedziwiatr M. 2013; Prognostic value of the Rockall score in patients with acute nonvariceal bleeding from the upper gastrointestinal tract. Przegl Lek. 70:1–5. PMID: 23789296.

12. Blatchford O, Davidson LA, Murray WR, Blatchford M, Pell J. 1997; Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study. BMJ. 315:510–514. DOI: 10.1136/bmj.315.7107.510. PMID: 9329304. PMCID: PMC2127364.

13. Stanley AJ, Ashley D, Dalton HR, et al. 2009; Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet. 373:42–47. DOI: 10.1016/S0140-6736(08)61769-9. PMID: 19091393.

14. Saltzman JR, Tabak YP, Hyett BH, Sun X, Travis AC, Johannes RS. 2011; A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc. 74:1215–1224. DOI: 10.1016/j.gie.2011.06.024. PMID: 21907980.

15. Green FW Jr, Kaplan MM, Curtis LE, Levine PH. 1978; Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology. 74:38–43. DOI: 10.1016/0016-5085(78)90352-9. PMID: 21830.

16. Lau JY, Leung WK, Wu JC, et al. 2007; Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med. 356:1631–1640. DOI: 10.1056/NEJMoa065703. PMID: 17442905.

17. Sreedharan A, Martin J, Leontiadis GI, et al. 2010; Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev. (7):CD005415. DOI: 10.1002/14651858.CD005415.pub3. PMID: 20614440. PMCID: PMC6769021.

18. Bardou M, Toubouti Y, Benhaberou-Brun D, Rahme E, Barkun AN. 2005; Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding. Aliment Pharmacol Ther. 21:677–686. DOI: 10.1111/j.1365-2036.2005.02391.x. PMID: 15771753.

19. Laine L, McQuaid KR. 2009; Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol. 7:33–47. DOI: 10.1016/j.cgh.2008.08.016. PMID: 18986845.

20. Jensen DM, Pace SC, Soffer E, Comer GM. 315 Study Group. 2006; Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study. Am J Gastroenterol. 101:1991–1999. DOI: 10.1111/j.1572-0241.2006.00773.x. PMID: 16968504.

21. Karstensen JG, Ebigbo A, Aabakken L, et al. 2018; Nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) cascade guideline. Endosc Int Open. 6:E1256–E1263. DOI: 10.1055/a-0677-2084. PMID: 30302383. PMCID: PMC6175685.

22. Laine L, Jensen DM. 2012; Management of patients with ulcer bleeding. Am J Gastroenterol. 107:345–360. DOI: 10.1038/ajg.2011.480. PMID: 22310222.

23. Sachar H, Vaidya K, Laine L. 2014; Intermittent vs continuous proton pump inhibitor therapy for high-risk bleeding ulcers: a systematic review and meta-analysis. JAMA Intern Med. 174:1755–1762. DOI: 10.1001/jamainternmed.2014.4056. PMID: 25201154. PMCID: PMC4415726.

24. Wysocki JD, Srivastav S, Winstead NS. 2012; A nationwide analysis of risk factors for mortality and time to endoscopy in upper gastrointestinal haemorrhage. Aliment Pharmacol Ther. 36:30–36. DOI: 10.1111/j.1365-2036.2012.05129.x. PMID: 22577955.

25. Laursen SB, Leontiadis GI, Stanley AJ, Møller MH, Hansen JM, Schaffalitzky de Muckadell OB. 2017; Relationship between timing of endoscopy and mortality in patients with peptic ulcer bleeding: a nationwide cohort study. Gastrointest Endosc. 85:936–944.e3. DOI: 10.1016/j.gie.2016.08.049. PMID: 27623102.

26. Tsoi KK, Ma TK, Sung JJ. 2009; Endoscopy for upper gastrointestinal bleeding: how urgent is it? Nat Rev Gastroenterol Hepatol. 6:463–469. DOI: 10.1038/nrgastro.2009.108. PMID: 19597510.

27. Cho SH, Lee YS, Kim YJ, et al. 2018; Outcomes and role of urgent endoscopy in high-risk patients with acute nonvariceal gastrointestinal bleeding. Clin Gastroenterol Hepatol. 16:370–377. DOI: 10.1016/j.cgh.2017.06.029. PMID: 28634135.

28. Restellini S, Kherad O, Jairath V, Martel M, Barkun AN. 2013; Red blood cell transfusion is associated with increased rebleeding in patients with nonvariceal upper gastrointestinal bleeding. Aliment Pharmacol Ther. 37:316–322. DOI: 10.1111/apt.12170. PMID: 23205554.

29. Fabricius R, Svenningsen P, Hillingsø J, Svendsen LB, Sillesen M. 2016; Effect of transfusion strategy in acute non-variceal upper gastrointestinal bleeding: a nationwide study of 5861 hospital admissions in Denmark. World J Surg. 40:1129–1136. DOI: 10.1007/s00268-015-3370-4. PMID: 26675926.

30. Subramaniam K, Spilsbury K, Ayonrinde OT, et al. 2016; Red blood cell transfusion is associated with further bleeding and fresh-frozen plasma with mortality in nonvariceal upper gastrointestinal bleeding. Transfusion. 56:816–826. DOI: 10.1111/trf.13446. PMID: 26718025.

31. Hajiagha Mohammadi AA, Reza Azizi M. 2019; Prognostic factors in patients with active non-variceal upper gastrointestinal bleeding. Arab J Gastroenterol. 20:23–27. DOI: 10.1016/j.ajg.2019.01.001. PMID: 30770260.

32. Roberts I, Evans P, Bunn F, Kwan I, Crowhurst E. 2001; Is the normal-isation of blood pressure in bleeding trauma patients harmful? Lancet. 357:385–387. DOI: 10.1016/S0140-6736(00)03653-9. PMID: 11211015.

33. Duggan JM. 2001; Review article: transfusion in gastrointestinal haemorrhage--if, when and how much? Aliment Pharmacol Ther. 15:1109–1113. DOI: 10.1046/j.1365-2036.2001.01013.x. PMID: 11472313.

34. Blair SD, Janvrin SB, McCollum CN, Greenhalgh RM. 1986; Effect of early blood transfusion on gastrointestinal haemorrhage. Br J Surg. 73:783–785. DOI: 10.1002/bjs.1800731007. PMID: 3533203.

35. Hearnshaw SA, Logan RF, Palmer KR, Card TR, Travis SP, Murphy MF. 2010; Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding. Aliment Pharmacol Ther. 32:215–224. DOI: 10.1111/j.1365-2036.2010.04348.x. PMID: 20456308.

36. Villanueva C, Colomo A, Bosch A, et al. 2013; Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 368:11–21. DOI: 10.1056/NEJMoa1211801. PMID: 23281973.

37. Jairath V, Kahan BC, Gray A, et al. 2015; Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet. 386:137–144. DOI: 10.1016/S0140-6736(14)61999-1. PMID: 25956718.

38. Laine L, Peterson WL. 1994; Bleeding peptic ulcer. N Engl J Med. 331:717–727. DOI: 10.1056/NEJM199409153311107. PMID: 8058080.

39. Lau JY, Sung JJ, Chan AC, et al. 1997; Stigmata of hemorrhage in bleeding peptic ulcers: an interobserver agreement study among international experts. Gastrointest Endosc. 46:33–36. DOI: 10.1016/S0016-5107(97)70206-2. PMID: 9260702.

40. Bleau BL, Gostout CJ, Sherman KE, et al. 2002; Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc. 56:1–6. DOI: 10.1067/mge.2002.125365. PMID: 12085028.

41. Kim HS. 2015; Endoscopic management of Mallory-Weiss tearing. Clin Endosc. 48:102–105. DOI: 10.5946/ce.2015.48.2.102. PMID: 25844336. PMCID: PMC4381135.

42. Harris JM, DiPalma JA. 1993; Clinical significance of Mallory-Weiss tears. Am J Gastroenterol. 88:2056–2058. PMID: 8249973.

43. Ljubičić N, Budimir I, Pavić T, et al. 2014; Mortality in high-risk patients with bleeding Mallory-Weiss syndrome is similar to that of peptic ulcer bleeding. Results of a prospective database study. Scand J Gastroenterol. 49:458–464. DOI: 10.3109/00365521.2013.846404. PMID: 24495010.

44. Chung IK, Kim EJ, Hwang KY, et al. 2002; Evaluation of endoscopic hemostasis in upper gastrointestinal bleeding related to Mallory-Weiss syndrome. Endoscopy. 34:474–479. DOI: 10.1055/s-2002-32000. PMID: 12048631.

45. Bharucha AE, Gostout CJ, Balm RK. 1997; Clinical and endoscopic risk factors in the Mallory-Weiss syndrome. Am J Gastroenterol. 92:805–808. PMID: 9149189.

46. Kortas DY, Haas LS, Simpson WG, Nickl NJ 3rd, Gates LK Jr. 2001; Mallory-Weiss tear: predisposing factors and predictors of a complicated course. Am J Gastroenterol. 96:2863–2865. DOI: 10.1111/j.1572-0241.2001.04239.x. PMID: 11693318.

47. Kim JW, Kim HS, Byun JW, et al. 2005; Predictive factors of recurrent bleeding in Mallory-Weiss syndrome. Korean J Gastroenterol. 46:447–454. PMID: 16371719.

48. Park CH, Min SW, Sohn YH, et al. 2004; A prospective, randomized trial of endoscopic band ligation vs.epinephrine injection for actively bleeding Mallory-Weiss syndrome. Gastrointest Endosc. 60:22–27. DOI: 10.1016/S0016-5107(04)01284-2. PMID: 15229420.

49. Huang SP, Wang HP, Lee YC, et al. 2002; Endoscopic hemoclip placement and epinephrine injection for Mallory-Weiss syndrome with active bleeding. Gastrointest Endosc. 55:842–846. DOI: 10.1067/mge.2002.124560. PMID: 12024138.

50. Lee S, Ahn JY, Jung HY, et al. 2016; Effective endoscopic treatment of Mallory-Weiss syndrome using Glasgow-Blatchford score and Forrest classification. J Dig Dis. 17:676–684. DOI: 10.1111/1751-2980.12409. PMID: 27624697.

51. Lecleire S, Antonietti M, Iwanicki-Caron I, et al. 2009; Endoscopic band ligation could decrease recurrent bleeding in Mallory-Weiss syndrome as compared to haemostasis by hemoclips plus epinephrine. Aliment Pharmacol Ther. 30:399–405. DOI: 10.1111/j.1365-2036.2009.04051.x. PMID: 19485979.

52. Shimoda R, Iwakiri R, Sakata H, et al. 2009; Endoscopic hemostasis with metallic hemoclips for iatrogenic Mallory-Weiss tear caused by endoscopic examination. Dig Endosc. 21:20–23. DOI: 10.1111/j.1443-1661.2008.00825.x. PMID: 19691796.

53. Saltzman JR, Strate LL, Di Sena V, et al. 2005; Prospective trial of endoscopic clips versus combination therapy in upper GI bleed-ing (PROTECCT--UGI bleeding). Am J Gastroenterol. 100:1503–1508. DOI: 10.1111/j.1572-0241.2005.41561.x. PMID: 15984972.

54. Barakat M, Hamed A, Shady A, Homsi M, Eskaros S. 2018; Endoscopic band ligation versus endoscopic hemoclip placement for Dieulafoy's lesion: a meta-analysis. Eur J Gastroenterol Hepatol. 30:995–996. DOI: 10.1097/MEG.0000000000001179. PMID: 30048368.

55. Senger JL, Kanthan R. 2012; The evolution of Dieulafoy's lesion since 1897: then and now-a journey through the lens of a pediatric lesion with literature review. Gastroenterol Res Pract. 2012:432517. DOI: 10.1155/2012/432517. PMID: 22474434. PMCID: PMC3296298.

56. Baxter M, Aly EH. 2010; Dieulafoy's lesion: current trends in diagnosis and management. Ann R Coll Surg Engl. 92:548–554. DOI: 10.1308/003588410X12699663905311. PMID: 20883603. PMCID: PMC3229341.

57. Chung IK, Kim EJ, Lee MS, et al. 2000; Bleeding Dieulafoy's lesions and the choice of endoscopic method: comparing the hemostatic efficacy of mechanical and injection methods. Gastrointest Endosc. 52:721–724. DOI: 10.1067/mge.2000.108040. PMID: 11115902.

58. Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Muñoz E. 2004; Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther. 19:617–629. DOI: 10.1111/j.1365-2036.2004.01898.x. PMID: 15023164.

59. Huang TC, Lee CL. 2014; Diagnosis, treatment, and outcome in patients with bleeding peptic ulcers and Helicobacter pylori infections. Biomed Res Int. 2014:658108. DOI: 10.1155/2014/658108. PMID: 25101293. PMCID: PMC4101224.

60. Samuel R, Bilal M, Tayyem O, Guturu P. 2018; Evaluation and manage-ment of non-variceal upper gastrointestinal bleeding. Dis Mon. 64:333–343. DOI: 10.1016/j.disamonth.2018.02.003. PMID: 29525375.

61. Leontiadis GI, Sharma VK, Howden CW. 2006; Proton pump inhibitor treatment for acute peptic ulcer bleeding. Cochrane Database Syst Rev. (1):CD002094. DOI: 10.1002/14651858.CD002094.pub3. PMID: 16437441.

62. Barkun AN, Bardou M, Kuipers EJ, et al. 2010; International consensus recommendations on the management of patients with non-variceal upper gastrointestinal bleeding. Ann Intern Med. 152:101–113. DOI: 10.7326/0003-4819-152-2-201001190-00009. PMID: 20083829.

63. Kim HK, Kim JS, Kim TH, et al. 2012; Effect of high-dose oral rabeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. Gastroenterol Res Pract. 2012:317125. DOI: 10.1155/2012/317125. PMID: 23049546. PMCID: PMC3463177.

64. Sung JJ, Suen BY, Wu JC, et al. 2014; Effects of intravenous and oral esomeprazole in the prevention of recurrent bleeding from peptic ulcers after endoscopic therapy. Am J Gastroenterol. 109:1005–1010. DOI: 10.1038/ajg.2014.105. PMID: 24777150.

65. El Ouali S, Barkun AN, Wyse J, et al. 2012; Is routine second-look en-doscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis. Gastrointest Endosc. 76:283–292. DOI: 10.1016/j.gie.2012.04.441. PMID: 22695209.

66. Imperiale TF, Kong N. 2012; Second-look endoscopy for bleeding peptic ulcer disease: a decision-effectiveness and cost-effectiveness analysis. J Clin Gastroenterol. 46:e71–e75. DOI: 10.1097/MCG.0b013e3182410351. PMID: 22298087. PMCID: PMC3343187.

67. Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. 2006; A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 27:2667–2674. DOI: 10.1093/eurheartj/ehl334. PMID: 17053008.

68. Sung JJ, Lau JY, Ching JY, et al. 2010; Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 152:1–9. DOI: 10.7326/0003-4819-152-1-201001050-00179. PMID: 19949136.

69. Derogar M, Sandblom G, Lundell L, et al. 2013; Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events. Clin Gastroenterol Hepatol. 11:38–42. DOI: 10.1016/j.cgh.2012.08.034. PMID: 22975385.

70. Eisenberg MJ, Richard PR, Libersan D, Filion KB. 2009; Safety of short-term discontinuation of antiplatelet therapy in patients with drugeluting stents. Circulation. 119:1634–1642. DOI: 10.1161/CIRCULATIONAHA.108.813667. PMID: 19289638.

71. Hur S, Jae HJ, Lee H, Lee M, Kim HC, Chung JW. 2017; Superselective embolization for arterial upper gastrointestinal bleeding using N-butyl cyanoacrylate: a single-center experience in 152 patients. J Vasc Interv Radiol. 28:1673–1680. DOI: 10.1016/j.jvir.2017.07.027. PMID: 28935474.

72. Beggs AD, Dilworth MP, Powell SL, Atherton H, Griffiths EA. 2014; A systematic review of transarterial embolization versus emergency surgery in treatment of major nonvariceal upper gastrointestinal bleeding. Clin Exp Gastroenterol. 7:93–104. DOI: 10.2147/CEG.S56725. PMID: 24790465. PMCID: PMC3998850.

73. Loffroy R, Estivalet L, Cherblanc V, et al. 2012; Transcatheter embolization as the new reference standard for endoscopically unmanageable upper gastrointestinal bleeding. World J Gastrointest Surg. 4:223–227. DOI: 10.4240/wjgs.v4.i10.223. PMID: 23467300. PMCID: PMC3587468.

74. Wang YR, Richter JE, Dempsey DT. 2010; Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006. Ann Surg. 251:51–58. DOI: 10.1097/SLA.0b013e3181b975b8. PMID: 20009753.

75. Guglielmi A, Ruzzenente A, Sandri M, et al. 2002; Risk assessment and prediction of rebleeding in bleeding gastroduodenal ulcer. Endoscopy. 34:778–786. DOI: 10.1055/s-2002-34261. PMID: 12244498.

76. Chung IK, Kim EJ, Lee MS, et al. 2001; Endoscopic factors predisposing to rebleeding following endoscopic hemostasis in bleeding peptic ulcers. Endoscopy. 33:969–975. DOI: 10.1055/s-2001-17951. PMID: 11668406.